================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549-1004
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 30, 2007
Amexdrug Corporation
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-7473 95-2251025
-------------- ----------- -------------------
(State of Commission (I.R.S. Employer
Incorporation) file number Identification No.)
8909 West Olympic Boulevard, Suite 208
Beverly Hills, California
--------------------------------------------------
(Address of principal executive offices, zip code)
(310) 855-0475
----------------------------------------------------
(Registrant's telephone number, including area code)
-------------------------------------------------
(Former Name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c)
ITEM 4.01. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
(a) On April 30, 2007, Hansen, Barnett & Maxwell, P.C. was terminated as the
certifying accountant for the Company (the "Registrant").
Hansen, Barnett & Maxwell, P.C. has served as the certifying accountant for the
Company's financial statements for more than the past three years. From the date
on which Hansen, Barnett & Maxwell, P.C. was engaged until the date Hansen,
Barnett & Maxwell, P.C. was terminated, there were no disagreements with Hansen,
Barnett & Maxwell, P.C. on any matter of accounting principles or practices,
financial statement disclosure, or auditing scope or procedure, which
disagreements, if not resolved to the satisfaction of Hansen, Barnett & Maxwell,
P.C. would have caused Hansen, Barnett & Maxwell, P.C. to make reference to the
subject matter of the disagreements in connection with any reports it would have
issued, and there were no "reportable events" as that term is defined in Item
304(a)(1)(iv) of Regulation S-B.
(b) On April 30, 2007, the Company entered into an engagement letter with HJ
Associates & Consultants, LLP to assume the role of its new certifying
accountant. HJ Associates & Consultants, LLP has been asked to audit the year
ended December 31, 2007. During the two most recent fiscal years and the
subsequent interim periods prior to the engagement of HJ Associates &
Consultants, LLP, the Company did not consult with HJ Associates & Consultants,
LLP with regard to:
(i) the application of accounting principles to a specified transaction, either
completed or proposed; or the type of audit opinion that might be rendered on
the Company's financial statements; or
(ii) any matter that was either the subject of a disagreement or a reportable
event (as described in Item 304(a)(1)(iv) of Regulation S-B).
The engagement of the new principal auditor was recommended and approved by the
Company's Board of Directors.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
16.1 Letter from Hansen Barnett & Maxwell, P.C. regarding its
concurrence or disagreement with the statement made by the
Registrant in this Current Report concerning the termination of
Hansen Barnett & Maxwell P.C. as the Registrant's principal
accountant.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEXDRUG CORPORATION
Date: May 2, 2007 /s/ Jack Amin
-----------------------
Jack Amin, President
- --------------------------------------------------------------------------------